Beta-testing data analysis

NC Nananda Col
SH Stephen Hull
VS Vicky Springmann
LN Long Ngo
EM Ernie Merritt
SG Susan Gold
MS Michael Sprintz
NG Noel Genova
NN Noah Nesin
BT Brenda Tierman
FS Frank Sanfilippo
RE Richard Entel
LP Lori Pbert
request Request a Protocol
ask Ask a question
Favorite

All data were directly entered by the patient into a Qualtrics database. Use of PainAPP pages was monitored via analysis of website log files. Mean time spent on different activities was computed after removing outliers that likely reflected break periods. We could not directly determine how much time participants spent on the control website because we did not have access to that website’s log file. Because of the small sample size, the limited scope of the beta-testing, and biases detected during beta-testing, limited statistical analyses were performed. Recruitment was ended before our initial target of 50 patients was achieved because of serious challenges discovered that prompted a reassessment of the study design. The initial target sample of 50 was estimated to provide an 80% chance of detecting a 20% improvement on the primary outcome COMRADE with a type-I error rate of 0.05 [67].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A